Sort
261,768 grants matching “gene therapy”
Pharmacogenomics of Anti-platelet Agents for CVD Prevention
$1,494,237Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2009 · GM
Molecular Studies Of Ovarian Cancer
$1,494,206Patrice J. Morin · Aging · Z01 · FY2007 · AG
Pathogenesis and Treatment of Muscular Dystrophy
$1,494,202Louis M Kunkel · Boston Children'S Hospital · P50 · FY2009 · NS
Dysregulation of metabolic and bioenergetic pathways by cocaine and HIV-1 in CNS
$1,494,058Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2015 · DA
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis
$1,493,635Colton Joseph Lloyd · Sinopia Biosciences, Inc. · R44 · FY2024 · DE
Pathogensis of Chlamydial Infection
$1,493,421Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
GENE THERAPY IN A NONHUMAN PRIMATE MODEL OF COGNITIVE DEFECTS IN PARKINSON'S DISEASE
$1,493,233The Trustees Of Columbia University In The City Of New York · · FY2024 · Defense Health Agency
HSC DIFFERENTIATION
$1,492,969Children'S Hospital Los Angeles · P50 · FY2002 · HL
Molecular Chaperones and DNA Replication
$1,492,861Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
$1,492,810Amitabh Chak · Case Western Reserve University · U54 · FY2019 · CA
Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD
$1,492,509Samuel V Alworth · Acurastem, Inc. · R44 · FY2023 · AG
Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias
$1,492,444Anumantha Gounder Kanthasamy · University Of Georgia · U01 · FY2024 · AG
GENETIC ALTERATIONS ON LIPOPROTEINS AND ATHEROSCLEROSIS
$1,492,396J. David Gladstone Institutes · P01 · FY2001 · HL
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa
$1,492,362William A. Beltran · University Of Pennsylvania · R24 · FY2012 · EY
Emory Specialized Center of Research Excellence (SCORE) on Sex Differences
$1,492,185Ighovwerha Ofotokun · Emory University · U54 · FY2021 · AG
ETIB Clinical Trials
$1,492,154Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
$1,491,988Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Area C: Functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies
$1,491,750David J Beebe · University Of Wisconsin-Madison · R33 · FY2017 · CA
PATHOBIOLOGY AND GENE TRANSFER IN CARDIOVASCULAR DISEASE
$1,491,672Baylor College Of Medicine · P01 · FY2004 · HL
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
$1,491,583Rhea N Coler · Access To Advanced Health Institute · U01 · FY2009 · AI
CD28-KITv CAR T cells with PD-1 dominant negative receptor
$1,491,519Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · UG3 · FY2024 · CA
Defining RAS isoform- and mutation-specific roles in oncogenesis
$1,491,448Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center
$1,491,322Richard J Samulski · Univ Of North Carolina Chapel Hill · U54 · FY2008 · AR
Cancer Center Support Grant
$1,491,285Michael J Weber · University Of Virginia · P30 · FY2006 · CA
Muscular Dystrophy Cooperative Research Center
$1,491,258University Of Rochester · U54 · FY2003 · NS